SELP and atherosclerosis: In this context, the value of P-selectin as a CVD biomarker remains to be clarified, independently of other established biomarkers that have demonstrated value for both screening and prognosis of atherosclerosis, i.e., cardiac troponins, natriuretic peptides, or C-reactive protein (CRP).